ScholarIQanswers from OpenAlex

Identification of Novel Predictive Markers for the Prognosis of Pancreatic Ductal Adenocarcinoma

PaperCitations, authors & open-access status

Identification of Novel Predictive Markers for the Prognosis of Pancreatic Ductal Adenocarcinoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Identification of Novel Predictive Markers for the Prognosis of Pancreatic Ductal Adenocarcinoma have?

ScholarIQcitation count

Identification of Novel Predictive Markers for the Prognosis of Pancreatic Ductal Adenocarcinoma has 42 citations in the OpenAlex counts ScholarIQ stores.

When was Identification of Novel Predictive Markers for the Prognosis of Pancreatic Ductal Adenocarcinoma published?

ScholarIQyear

Identification of Novel Predictive Markers for the Prognosis of Pancreatic Ductal Adenocarcinoma has 2014 year in the ScholarIQ index.

What is the open-access status of Identification of Novel Predictive Markers for the Prognosis of Pancreatic Ductal Adenocarcinoma?

ScholarIQoa status

Identification of Novel Predictive Markers for the Prognosis of Pancreatic Ductal Adenocarcinoma has closed oa status in the ScholarIQ index.

What is the DOI of Identification of Novel Predictive Markers for the Prognosis of Pancreatic Ductal Adenocarcinoma?

ScholarIQdoi

The DOI for Identification of Novel Predictive Markers for the Prognosis of Pancreatic Ductal Adenocarcinoma is on the source record.

What is the PMID of Identification of Novel Predictive Markers for the Prognosis of Pancreatic Ductal Adenocarcinoma?

ScholarIQpmid

The PMID for Identification of Novel Predictive Markers for the Prognosis of Pancreatic Ductal Adenocarcinoma is on the source record.

What is the OpenAlex record for Identification of Novel Predictive Markers for the Prognosis of Pancreatic Ductal Adenocarcinoma?

ScholarIQopenalex

The OpenAlex for Identification of Novel Predictive Markers for the Prognosis of Pancreatic Ductal Adenocarcinoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial